AGN Technical Analysis
As of date:5/8/2020
AGN stock price:193.02
AGN 50 DMA:182.37
AGN 200 DMA:177.76
AGN MACD (200-50):-4.61
AGN RSI:62.86
Extremely
Overbought
Overbought/Oversold RSI Range
RSI Indicator (Relative Strength Index)62.86
Extremely
Oversold

Also see:
AGN Market Cap History
AGN Shares Outstanding History
AGN YTD Return

Quotes delayed 20 minutes
Get Free SEC filing alerts for AGN:
AGN SEC Filing Email Alerts ServiceExternal link

VKTX Crosses Below Key Moving Average Level
Thursday, July 2, 5:13 PM


Itochu (ITOCY) Shares Cross Above 200 DMA
Thursday, July 2, 5:10 PM


Bullish Two Hundred Day Moving Average Cross - GBAB
Thursday, July 2, 5:10 PM


CTDD Crosses Above Key Moving Average Level
Thursday, July 2, 5:09 PM


TOU.CA Makes Bullish Cross Above Critical Moving Average
Thursday, July 2, 5:06 PM


Clearwater Seafoods Breaks Above 200-Day Moving Average - Bullish for CLR.CA
Thursday, July 2, 5:06 PM


BGY Crosses Above Key Moving Average Level
Thursday, July 2, 5:06 PM


Martinrea International Breaks Above 200-Day Moving Average - Bullish for MRE.CA
Thursday, July 2, 5:06 PM


Bullish Two Hundred Day Moving Average Cross - CASA
Thursday, July 2, 11:53 AM


Bullish Two Hundred Day Moving Average Cross - SINA
Thursday, July 2, 11:48 AM


ICU Medical (ICUI) Shares Cross Above 200 DMA
Thursday, July 2, 11:37 AM


Bullish Two Hundred Day Moving Average Cross - OSB
Thursday, July 2, 11:36 AM


CAR Makes Bullish Cross Above Critical Moving Average
Thursday, July 2, 11:36 AM


Bullish Two Hundred Day Moving Average Cross - INFY
Thursday, July 2, 11:33 AM


National Grid Breaks Below 200-Day Moving Average - Notable for NGG
Thursday, July 2, 11:33 AM


More Technical Analysis News

AGN Technical AnalysisAGN RSI
Allergan is a pharmaceutical company focused on developing, manufacturing and commercializing pharmaceutical, device, biologic, surgical and regenerative medicine products for patients around the world. Co. has three segments: United States Specialized Therapeutics, which includes products within the United States, including Medical Aesthetics, Medical Dermatology Eye Care and Neuroscience and Urology therapeutic products; United States General Medicine, which includes products within the United States that do not fall into the United States Specialized Therapeutics business units, including Central Nervous System; and International, which includes products sold outside the United States.

When researching a stock like Allergan, many investors are the most familiar with Fundamental Analysis — looking at a company's balance sheet, earnings, revenues, and what's happening in that company's underlying business. Investors who use Fundamental Analysis to identify good stocks to buy or sell can also benefit from AGN Technical Analysis to help find a good entry or exit point. Technical Analysis is blind to the fundamentals and looks only at the trading data for AGN stock — the real life supply and demand for the stock over time — and examines that data in different ways.
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks

10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
AGN DMAAGN MACD
Video: Technical Analysis


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Allergan (AGN) is categorized under the Healthcare sector; to help you further research Technical Analysis, below are some other companies in the same sector:

ALGN Technical Analysis
ALXN Technical Analysis
AMGN Technical Analysis
BAX Technical Analysis
BDX Technical Analysis
BIIB Technical Analysis
BMY Technical Analysis
BSX Technical Analysis
CAH Technical Analysis
CELG Technical Analysis
More Healthcare companies »

 

AGN Technical Analysis | www.TechnicalAnalysisChannel.com | Copyright © 2019 - 2020, All Rights Reserved

Nothing in TechnicalAnalysisChannel.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.